European headache federation consensus on the definition of resistant and refractory migraine Developed with the endorsement of the European Migraine & Headache Alliance (EMHA)
Top Cited Papers
Open Access
- 15 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in The Journal of Headache and Pain
- Vol. 21 (1), 1-12
- https://doi.org/10.1186/s10194-020-01130-5
Abstract
Introduction Despite advances in the management of headache disorders, some patients with migraine do not experience adequate pain relief with acute and preventive treatments. It is the aim of the present document to provide a definition of those migraines which are difficult-to-treat, to create awareness of existence of this group of patients, to help Healthcare Authorities in understanding the implications, and to create a basis to develop a better pathophysiological understanding and to support further therapeutic advances. Main body Definitions were established with a consensus process using the Delphi method. Patients with migraine with or without aura or with chronic migraine can be defined as havingresistant migraineandrefractory migraineaccording to previous preventative failures.Resistant migraineis defined by having failed at least 3 classes of migraine preventatives and suffer from at least 8 debilitating headache days per month for at least 3 consecutive months without improvement; definition can be based on review of medical charts.Refractory migraineis defined by having failed all of the available preventatives and suffer from at least 8 debilitating headache days per month for at least 6 consecutive months. Drug failure may include lack of efficacy or lack of tolerability. Debilitating headache is defined as headache causing serious impairment to conduct activities of daily living despite the use of pain-relief drugs with established efficacy at the recommended dose and taken early during the attack; failure of at least two different triptans is required. Conclusions We hope, that the updated EHF definition will be able to solve the conflicts that have limited the use of definitions which have been put forward in the past. Only with a widely accepted definition, progresses in difficult-to-treat migraine can be achieved. This new definition has also the aim to increase the understanding of the impact of the migraine as a disease with all of its social, legal and healthcare implications. It is the hope of the EHF Expert Consensus Group that the proposed criteria will stimulate further clinical, scientific and social attention to patients who suffer from migraine which is difficult-to-treat.Keywords
This publication has 64 references indexed in Scilit:
- Headache and SleepHeadache: The Journal of Head and Face Pain, 2013
- The Stigma of MigrainePLOS ONE, 2013
- Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS)The Journal of Headache and Pain, 2012
- Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonrespondersThe Journal of Headache and Pain, 2011
- Recommendations for headache service organisation and delivery in EuropeThe Journal of Headache and Pain, 2011
- EFNS guideline on the drug treatment of migraine – revised report of an EFNS task forceEuropean Journal of Neurology, 2009
- Comorbid neuropathologies in migraine: an update on cerebrovascular and cardiovascular aspectsThe Journal of Headache and Pain, 2008
- When should “chronic migraine” patients be considered “refractory” to pharmacological prophylaxis?Neurological Sciences, 2008
- Comorbid neuropathologies in migraineThe Journal of Headache and Pain, 2006
- Clinical Utility of an Instrument Assessing Migraine Disability: The Migraine Disability Assessment (MIDAS) QuestionnaireHeadache: The Journal of Head and Face Pain, 2001